Yan-Wei Hu Selected Research

Lipopolysaccharides

7/2020	Lipopolysaccharide Promotes Inflammatory Response via Enhancing IFIT1 Expression in Human Umbilical Vein Endothelial Cells.
5/2013	Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1α-dependent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan-Wei Hu Research Topics

Disease

33	Atherosclerosis 07/2022 - 05/2008
12	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2010
7	Inflammation (Inflammations) 12/2020 - 05/2013
6	Neoplasms (Cancer) 07/2019 - 06/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2014
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 03/2014
4	Glioma (Gliomas) 01/2022 - 01/2018
3	Infections 09/2018 - 04/2014
3	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2016
2	Coronary Disease (Coronary Heart Disease) 12/2019 - 12/2015
1	Necrosis 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Wounds and Injuries (Trauma) 11/2020
1	Trichothiodystrophy Syndromes 01/2020
1	Vascular Calcification 01/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2018
1	Rupture 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 09/2017
1	Carotid Artery Diseases 11/2016
1	Hepatitis B 07/2016
1	Obesity 01/2016
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 01/2015
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011
1	Uterine Cervical Dysplasia 08/2010
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2010

Drug/Important Bio-Agent (IBA)

18	Long Noncoding RNAIBA 01/2022 - 03/2014
14	CholesterolIBA 01/2021 - 05/2010
9	CytokinesIBA 06/2019 - 05/2010
8	Proteins (Proteins, Gene)FDA Link 07/2020 - 04/2015
6	Apolipoproteins E (ApoE)IBA 01/2016 - 01/2013
5	oxidized low density lipoproteinIBA 12/2020 - 04/2014
5	Interleukin-6 (Interleukin 6)IBA 07/2020 - 05/2013
5	Biomarkers (Surrogate Marker)IBA 12/2019 - 08/2010
4	LipidsIBA 01/2020 - 01/2014
3	C-Reactive ProteinIBA 09/2018 - 01/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2022 - 08/2020
2	Cell Adhesion MoleculesIBA 08/2020 - 06/2019
2	LipopolysaccharidesIBA 07/2020 - 05/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 01/2015
2	Messenger RNA (mRNA)IBA 12/2019 - 07/2016
2	Antisense RNA (Anti-Sense RNA)IBA 01/2019 - 11/2016
2	InterleukinsIBA 01/2018 - 05/2013
2	HDL CholesterolIBA 01/2018 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 08/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 05/2013
2	ApolipoproteinsIBA 01/2015 - 03/2014
2	Apolipoproteins MIBA 03/2014 - 02/2010
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	FibrinIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2020
1	InflammasomesIBA 12/2020
1	Biological ProductsIBA 11/2020
1	Phosphotransferases (Kinase)IBA 08/2020
1	InterferonsIBA 07/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Atorvastatin (Lipitor)FDA Link 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2019
1	Untranslated RNA (Noncoding RNA)IBA 07/2019
1	F-actin-binding proteinsIBA 01/2019
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	ProcalcitoninIBA 09/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2018
1	Troponin IIBA 01/2018
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2018
1	AlarminsIBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	incobotulinumtoxinA FDA Link 09/2017
1	Dopamine (Intropin)FDA LinkGeneric 09/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	Type A Botulinum Toxins (Botox)FDA Link 09/2017
1	Therapeutic UsesIBA 03/2017
1	OsteopontinIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 07/2016
1	hepatitis B virus X proteinIBA 07/2016
1	beta-Lactamases (beta-Lactamase)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	human MIRN573 microRNAIBA 10/2015
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2015
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2015
1	VLDL CholesterolIBA 01/2015
1	LDL CholesterolIBA 01/2015
1	dihydrocapsaicinIBA 03/2014
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2014
1	Propofol (Diprivan)FDA LinkGeneric 05/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2013
1	Advanced Oxidation Protein Products (AOPP)IBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	telomerase RNA (bTR)IBA 08/2010
1	Lipoproteins (Lipoprotein)IBA 02/2010

Therapy/Procedure

4	Therapeutics 01/2019 - 05/2017